PT ITAMA RANORAYA TBK PT Itama Ranoraya Tbk Share Price
Equities
IRRA
ID1000151707
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 474 IDR | -3.27% |
|
-2.47% | -40.75% |
| 04-02 | PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sales 2022 | 754B 46.72M 3.7B | Sales 2023 | 696B 43.17M 3.42B | Capitalization | 1,250B 77.5M 6.14B |
|---|---|---|---|---|---|
| Net income 2022 | 48B 2.98M 236M | Net income 2023 | 5.2B 322K 25.54M | EV / Sales 2022 | 2.3 x |
| Net Debt 2022 | 43.42B 2.69M 213M | Net Debt 2023 | 149B 9.23M 731M | EV / Sales 2023 | 2.01 x |
| P/E ratio 2022 |
35.2
x | P/E ratio 2023 |
238
x | Employees | 221 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 13.22% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.27% | ||
| 1 week | -2.47% | ||
| Current month | -15.36% | ||
| 1 month | -15.36% | ||
| 3 months | -1.25% | ||
| 6 months | -2.87% | ||
| Current year | -40.75% |
1 week
472.00
505.00
1 month
472.00580.00
Current year
462.00815.00
1 year
436.001 045.00
3 years
436.002 280.00
5 years
350.004 390.00
10 years
350.004 390.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | - | |
| Comptroller/Controller/Auditor | 37 | 31/03/20 | |
Dodi Nurzani
PRN | Corporate Officer/Principal | 60 | 31/12/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 31/12/21 | |
| Corporate Secretary | 61 | 31/12/18 | |
Tjandra Aditama
CHM | Chairman | 69 | 12/11/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 474 | -3.27% | 1,881,400 |
| 25/04/24 | 490 | 0.00% | 1,436,000 |
| 24/04/24 | 490 | 0.00% | 2,013,600 |
| 23/04/24 | 490 | +0.82% | 1,878,100 |
| 22/04/24 | 486 | 0.00% | 2,194,100 |
End-of-day quote INDONESIA S.E., April 25, 2024
More quotes
PT Itama Ranoraya Tbk is an Indonesia-based healthcare company, which is engaged in offering healthcare solutions. The Company operates in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. The Company carries out its operations through four products, namely the non-electromedical sterile medical devices, in-vitro diagnostic, electromedical sterile medical devices, and other products. Its business segment focuses on in-vitro diagnostic (IVD), medical imaging, surgical instrument and disposable, critical care, blood banking and transfusion, cardiovascular, brain management, cancer, urology, and maternal and neonatal care. Its products include Oneject, Abbott, Terumo, Becton Dickinson (BD), HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue.
Calendar
31/07/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -40.75% | 44.06M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- IRRA Stock
